DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy.
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk
DUE: February 7, 2024 Funding available to provide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies.
DUE: February 1, 2024 Supporting research designed to advance fundamental understanding of basic disease-related molecular mechanisms of vascular contributions to cognitive impairment and dementia (VCID).
DUE: February 14, 2024 Funding opportunity to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa.
Due: January 22, 2024 Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI) The Medical Technology Enterprise Consortium (MTEC) is excited to post this Request for Project Proposals (RPP) to solicit current MTEC members for a broad Read More
Due: November 14, 2023 This initiative seeks proposals from the small business community to support the development of compact tools and devices capable of manufacturing key chemical intermediates at the benchtop for research operations.
Due: November 14, 2023 The development of an accurate, inexpensive home test for Prostate Specific Antigen (PSA) is both an unmet need and an NCI priority for reducing cancer mortality by half within 25 years.
Due: November 14, 2023 The overarching goal of this initiative is to bring new alternatives for HPV testing to the market that will enable self-testing programs to be established globally at point-of-care or near point-of-care.
Due: November 17, 2023 The RADx® Tech Fetal Monitoring Challenge will award up to $2.0 million in prizes to accelerate the development of diagnostic and monitoring technologies to reduce the risk of fetal morbidity and Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.